Prevention and Treatment of Venous Thromboembolic Disease

Prescriber - United Kingdom
doi 10.1002/psb.1686
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Antithrombotic Therapy for Venous Thromboembolic Disease

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Venous Thromboembolic Disease in Burkina Faso: Results of the Prospective Registry REMAVET (Registry of Venous Thromboembolic)

Open Journal of Cardiology
2017English

A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pharmacoeconomic Aspects of the Prevention of Venous Thromboembolic Events After Large Joints Replacement

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2015English

Cancer and Venous Thromboembolic Disease: From Molecular Mechanisms to Clinical Management

Current Oncology
Oncology
2014English

Use of Low-Molecular-Weight Heparin in the Treatment of Venous Thromboembolic Disease: Answers to Frequently Asked Questions

Mayo Clinic Proceedings
Medicine
1998English

Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy - Occurrence and Relation to Disease Onset

Arthritis Care and Research
Rheumatology
2018English

New Oral Antithrombotics: Focus on Dabigatran, an Oral, Reversible Direct Thrombin Inhibitor for the Prevention and Treatment of Venous and Arterial Thromboembolic Disorders

Vascular Health and Risk Management
2012English

Oral Anticoagulants in the Treatment of Venous Thromboembolic Complications: Focus on Apixaban

Medical Council
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy